Home › Funds › Israel Discount Bank of New York › BIIB
Israel Discount Bank of New York position in BIIB
BIOGEN INC · Health Care
Israel Discount Bank of New York reported holding 1,055 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$238K, representing 0.43% of its reported portfolio and ranking #42 among its reported holdings. Israel Discount Bank of New York has disclosed BIIB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How Israel Discount Bank of New York's BIIB position evolved
Israel Discount Bank of New York first disclosed a stake in BIIB in Q3 2023 at 2,210 shares (US$568K). Across 9 filings, Israel Discount Bank of New York increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,055 shares valued at US$238K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.21K | $567.99K | New |
| Q4 2023 | 2.13K | $550.14K | Reduce |
| Q1 2024 | 1.62K | $349.97K | Reduce |
| Q2 2024 | 1.24K | $287.69K | Reduce |
| Q3 2024 | 1.32K | $256.45K | Add |
| Q4 2024 | 1.41K | $214.85K | Add |
| Q3 2025 | 1.45K | $203.54K | New |
| Q2 2026 | 1.05K | $227.94K | New |
| Q3 2026 | 1.05K | $238.30K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Israel Discount Bank of New York
FAQ
How long has Israel Discount Bank of New York held BIIB?
Israel Discount Bank of New York has disclosed BIIB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is Israel Discount Bank of New York's current position in BIIB?
As of Q3 2026, Israel Discount Bank of New York holds 1.05K shares of BIIB (BIOGEN INC), valued at $238.30K, representing 0.43% of its reported portfolio and ranking #42.
Has Israel Discount Bank of New York been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Israel Discount Bank of New York held unchanged its position in BIIB.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.